ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental liver cancer drug shows early promise in small trial
Disease control CompletedThis early-phase study tested a drug called itacitinib in 19 adults with advanced liver cancer (hepatocellular carcinoma) that had worsened after initial treatment. The goal was to see if itacitinib is safe and can shrink tumors or slow cancer growth. The drug works by blocking a…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Imperial College London • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New drug combo shows promise for tough liver cancers
Disease control CompletedThis study tested a combination of two drugs, futibatinib and pembrolizumab, in 14 adults with advanced or metastatic liver cancer that had not responded to prior treatment. The goal was to see if the combination could stop or slow cancer growth. Participants received both drugs,…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Liver cancer drug shows promise in late-stage trial
Disease control CompletedThis study tested the drug sorafenib in 50 adults with advanced liver cancer that could not be removed by surgery and had worsened after at least one prior treatment. The goal was to see how long the cancer stayed under control and to check for side effects. Results help doctors …
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Bo Hyun Kim • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New scan could sharpen view of liver cancer spread
Diagnosis CompletedThis study tested whether a special PET scan using a radioactive tracer (68Ga-PSMA) can improve how doctors see and manage advanced liver cancer that has spread. 29 adults with liver cancer not treatable by surgery or transplant took part. The scan targets a protein common on liv…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 26, 2026 06:49 UTC
-
Liver cancer study reveals which organs respond best to drug combo
Knowledge-focused CompletedThis study looked at 131 people with advanced liver cancer to see how a combination of two drugs (atezolizumab and bevacizumab) affects tumors in different parts of the body. The goal was to understand why some tumors shrink and others don't, especially in the liver. Researchers …
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Sponsor: CHA University • Aim: Knowledge-focused
Last updated May 04, 2026 16:17 UTC